Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis

M. Petrich, Adam; Gandhi, Mitul; Jovanovic, Borko; J. Castillo, Jorge; Rajguru, Saurabh; T. Yang, David; A. Shah, Khushboo; D. Whyman, Jeremy; Lansigan, Frederick; J. Hernandez-Ilizaliturri, Francisco; X. Lee, Lisa; K. Barta, Stefan; Melinamani, Shruthi; Karmali, Reem; Adeimy, Camille; Smith, Scott; Dalal, Neil; Nabhan, Chadi; Peace, David; Vose, Julie; M. Evens, Andrew; Shah, Namrata; S. Fenske, Timothy; D. Zelenetz, Andrew; J. Landsburg, Daniel; Howlett, Christina; Mato, Anthony; Jaglal, Michael; C. Chavez, Julio; P. Tsai, Judy; Reddy, Nishitha; Li, Shaoying; Handler, Caitlin; R. Flowers, Christopher; B. Cohen, Jonathon; A. Blum, Kristie; Song, Kevin; (Linda) Sun, Haowei; Press, Oliver; Cassaday, Ryan; Jaso, Jesse; Jeffrey Medeiros, L.; R. Sohani, Aliyah; S. Abramson, Jeremy

doi:10.1182/blood-2014-05-578963

Public

Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis

Shared by NobleBlocks on Oct 9, 2014 • 12:00 AM UTC

Authors:

Adam M. Petrich

Mitul Gandhi

Borko Jovanovic

Abstract

Key Points A subset of DHL patients may be cured, and some patients may benefit from intensive induction. Further investigations into the roles of SCT and novel agents are needed.

Discussions